Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Rovi Q1 Net Profit At 9.4 Mln Euros

May 6 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC:

Q1 OPERATING REVENUE 152.5 MILLION EUROS

Q1 EBITDA 20.3 MILLION EUROS

Q1 NET PROFIT 9.4 MILLION EUROS

EXPECTS ITS 2026 OPERATING REVENUE TO CONTINUE TO INCREASE COMPARED TO 2025, ALTHOUGH BY A LOW- TO MID-SINGLE-DIGIT PERCENTAGE

THIS IS MORE MODERATE GROWTH SCENARIO FOR 2026 THAN PREVIOUSLY ANNOUNCED AND IS SUBJECT TO VARIOUS FACTORS

Source text

Further company coverage: ROVI.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))

Recent news on Laboratorios Farmaceuticos Rovi

See all news